Amundi’s Oak Street Health, Inc. OSH Stock Holding History

Amundi’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,347	Closed	-$1.19M	–	1743
2021 Q4	$1.19M	Buy	50,347 +5,785	+13%	+$219K	﹤0.01%	1270
2021 Q3	$1.9M	Buy	44,562 +16,275	+58%	+$875K	﹤0.01%	1204
2021 Q2	$1.66M	Buy	+28,287	New	+$1.68M	﹤0.01%	1174

Other funds holding OSH

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Amundi's OSH Position: Q1 2022 in Review

Amundi sold out of Oak Street Health, Inc. (OSH) in Q1 2022, closing a stake of 50,347 shares — an estimated $1.19M sold.

Amundi first reported a position in OSH in Q2 2021 and held it in 3 quarters. The position peaked at $1.9M in Q3 2021. 209 funds tracked by Wall St. Rank hold OSH as of Q1 2022.

Amundi reported no remaining Oak Street Health, Inc. position as of Q1 2022 after selling out during the quarter.
Amundi sold 50,347 Oak Street Health, Inc. shares in Q1 2022, an estimated $1.19M.
Amundi first reported a position in Oak Street Health, Inc. in Q2 2021 and held it in 3 quarters.
Amundi's Oak Street Health, Inc. position peaked at $1.9M in Q3 2021.
209 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q1 2022.

Based on Amundi's 13F filing for Q1 2022, filed 16 May 2022.